Today: 22 March 2026
Browse Category

NYSE:PLTR 2 July 2025 - 19 August 2025

AI Stock Frenzy: Nvidia’s $300B Vision, Google’s Big Bet, and Palantir’s Setback – August 18–19, 2025 Roundup

AI Stock Frenzy: Nvidia’s $300B Vision, Google’s Big Bet, and Palantir’s Setback – August 18–19, 2025 Roundup

Cantor Fitzgerald raised Nvidia’s price target to $240 on Aug. 18, 2025, citing a bullish data-center outlook and the upcoming "Blackwell" GPU. Nvidia shares rose nearly 1%. Palantir stock fell 1.8% after Andrew Left called it "grossly overvalued." C3.ai announced a partnership with Brazil’s Eletrobras to deploy AI across the power grid.
AI Stock Frenzy: Hedge Funds Pile In, Tesla’s Dojo U-Turn & Palantir’s Reality Check

AI Stock Frenzy: Hedge Funds Pile In, Tesla’s Dojo U-Turn & Palantir’s Reality Check

Bridgewater Associates more than doubled its Nvidia stake to 7.23 million shares, worth $1.14 billion, and sharply increased holdings in Alphabet and Microsoft in Q2. Tiger Global Management added 4 million Amazon shares, ending June with 10 million. U.S. authorities approved Nvidia and AMD to resume AI chip sales to China, with revenue-sharing requirements. Tesla halted its Dojo AI supercomputer project and shifted to in-house AI chips.
AI Stocks Roar to Record Highs Amid Bold Deals and China Backlash (Aug 12–13, 2025 Roundup)

AI Stocks Roar to Record Highs Amid Bold Deals and China Backlash (Aug 12–13, 2025 Roundup)

Nasdaq Composite and S&P 500 closed at record highs August 12 as AI stocks surged and inflation cooled. Nvidia hit an intraday high near $184.50, pushing its market cap toward $4.5 trillion. Perplexity AI made a $34.5 billion cash offer for Google’s Chrome, lifting Alphabet shares. Japan’s Nikkei 225 jumped 2.2% to 42,718, with SoftBank up 6.9% at a record.
AI Stocks Frenzy: Soaring Earnings, Mega-Deals & Chip Shocks Drive Market (Aug 10–11, 2025)

AI Stocks Frenzy: Soaring Earnings, Mega-Deals & Chip Shocks Drive Market (Aug 10–11, 2025)

Palantir topped $1 billion in Q2 revenue for the first time and raised guidance, sending shares up 4%. SoundHound AI’s Q2 revenue jumped 217% to $42.7 million, beating estimates by $10 million. C3.ai warned of weak sales, triggering a 14% after-hours drop and a CEO rebuke. SoftBank posted ¥422 billion profit, pledged $30 billion to OpenAI, and surged 13% as Tokyo’s Topix hit a record.
AI Stocks Frenzy: GPT-5 Hype, Record Highs & Billion-Dollar Bets Fuel Aug 8–9 Market Surge

AI Stocks Frenzy: GPT-5 Hype, Record Highs & Billion-Dollar Bets Fuel Aug 8–9 Market Surge

The U.S. began licensing Nvidia to export H20 AI chips to China on Aug. 7, reversing a ban. OpenAI launched GPT-5 the same day, citing 700 million ChatGPT users. AMD shares dropped 5.1% and SMCI plunged 18.2% after weak Q2 data-center results. The Nasdaq Composite notched its 18th record high of 2025 on Aug. 8, led by AI and tech stocks.
Tech News Today: The Biggest Stories in Technology, Science, and Innovation (July 9, 2025) / Updated: 2025, July 9th, 00:00 CET

Tech News Today: The Biggest Stories in Technology, Science, and Innovation (July 9, 2025) / Updated: 2025, July 9th, 00:00 CET

A new axion Dark Energy model from Cornell and Shanghai Jiao Tong University predicts the universe will begin contracting in about 7 billion years, leading to a collapse in 33–34 billion years. The model challenges previous theories of endless expansion, suggesting dark energy evolves over time rather than remaining constant.
AI Stocks Soar to New Highs: Trends, Big Moves & What Analysts Predict Next

AI Stocks Soar to New Highs: Trends, Big Moves & What Analysts Predict Next

Nvidia reached a $1 trillion valuation in 2023 and holds about 80% of the AI chip market, powering most modern AI models. The S&P 500’s Magnificent Seven now account for nearly 35% of the index’s market cap and have generated over 70% of its gains since early 2023. Microsoft invested $10 billion in OpenAI and integrated GPT models across its platforms. Amazon, Alphabet, AMD, Palantir, and IBM expanded AI offerings and reported rapid revenue growth.
1 10 11 12

Stock Market Today

  • Savara (SVRA) Faces Valuation Questions After Share Price Decline
    March 22, 2026, 5:08 PM EDT. Savara (SVRA) shares have declined 3.88% over one day and 23.34% in three months, raising concerns among investors. Despite this, the one-year total shareholder return remains strong at 75.89%. The clinical-stage biotech, focused on rare respiratory diseases, is loss-making with no current revenue. It trades at a price-to-book (P/B) ratio of 6.2x, notably above the US biotech sector average of 2.5x and peer average of 4.5x, signaling potentially rich valuation based on future growth expectations. Investors are cautious as ongoing losses of $118.8 million and key Phase 3 trial outcomes could impact valuation. With limited financial models available, the stock appears overvalued. Market watchers should carefully weigh the high risk and reward profile, while diversifying their portfolios beyond Savara.
Go toTop